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Abstract
Background: Among scorpion species, the Buthidae produce the most deadly and painful venoms. However, little is known
regarding the venom components that cause pain and their mechanism of action. Using a paw-licking assay (Mus musculus),
this study compared the pain-inducing capabilities of venoms from two species of New World scorpion (Centruroides
vittatus, C. exilicauda) belonging to the neurotoxin-producing family Buthidae with one species of non-neurotoxin
producing scorpion (Vaejovis spinigerus) in the family Vaejovidae. A pain-inducing a-toxin (CvIV4) was isolated from the
venom of C. vittatus and tested on five Na
+ channel isoforms.
Principal Findings: C. vittatus and C. exilicauda venoms produced significantly more paw licking in Mus than V. spinigerus
venom. CvIV4 produced paw licking in Mus equivalent to the effects of whole venom. CvIV4 slowed the fast inactivation of
Nav1.7, a Na
+ channel expressed in peripheral pain-pathway neurons (nociceptors), but did not affect the Nav1.8-based
sodium currents of these neurons. CvIV4 also slowed the fast inactivation of Nav1.2, Nav1.3 and Nav1.4. The effects of CvIV4
are similar to Old World a-toxins that target Nav1.7 (AahII, BmK MI, LqhIII, OD1), however the primary structure of CvIV4 is
not similar to these toxins. Mutant Nav1.7 channels (D1586A and E1589Q, DIV S3–S4 linker) reduced but did not abolish the
effects of CvIV4.
Conclusions: This study: 1) agrees with anecdotal evidence suggesting that buthid venom is significantly more painful than
non-neurotoxic venom; 2) demonstrates that New World buthids inflict painful stings via toxins that modulate Na
+ channels
expressed in nociceptors; 3) reveals that Old and New World buthids employ similar mechanisms to produce pain. Old and
New World a-toxins that target Nav1.7 have diverged in sequence, but the activity of these toxins is similar. Pain-inducing
toxins may have evolved in a common ancestor. Alternatively, these toxins may be the product of convergent evolution.
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Introduction
For animals that lack the advantage of size, razor-like claws,
speed, camouflage, etc. to overpower or outmaneuver their pre-
dators, painful venom can serve as a potent weapon. A diversity of
animals including ants, wasps, bees, scorpions, spiders, snakes,
jellyfish, stonefish, and stingrays employ painful venom to either
deter their enemies or escape subjugation.
Among all species of scorpion, those in the family Buthidae
produce the world’s most deadly venoms [1]. Buthid venom is a
mixture of several peptides that bind different families of ion
channels (Na
+,K
+,C l
2,C a
2+) in excitable membranes of nerve
and muscle [2,3,4,5]. The majority of toxins that have been
described recognize either sodium (Na
+) or potassium (K
+)
channels. Toxins that bind Na
+ channels alter the gating
mechanism, making the channel likely to open near the resting
membrane potential and then inhibiting fast inactivation, thus
prolonging the flow of Na
+ ions through the pore [6,7]. Toxins
that bind K
+ channels block the flow of K
+ ions through the
channel, preventing the membrane from returning to its resting
potential after depolarization [8,9]. The synergistic effect of these
toxins is hyper-excitability of nerve and muscle cells that can cause
a wide range of physiological malfunction [10,11,12,13]. Even
when buthid stings are not fatal, humans report excruciating pain
that may last from several hours to days. While the buthid toxins
that cause seizures, paralysis and respiratory failure have been well
PLoS ONE | www.plosone.org 1 August 2011 | Volume 6 | Issue 8 | e23520studied, little is known regarding the venom components that
cause pain and their mechanism of action.
Animals sense pain when peripheral sensory neurons (nocicep-
tors) are activated [14,15] and transmit information about noxious
stimuli to the central nervous system (CNS). The cell bodies of
nociceptors are housed in dorsal root ganglia (DRG), located just
outside the spinal cord. A number of distinct DRG-expressed
voltage-gated sodium channels (VGSCs), primarily Nav1.7, Nav1.8,
Nav1.9, play a major role in transducing noxious stimuli in animals.
Given that buthid scorpions produce toxins that bind Na
+
channels in excitable membranes, it is plausible that their venom
induces pain by initiating action potentials in nociceptors. Because
some human pain disorders involve Na
+ channels expressed in
nociceptors [14,15], there has been an effort, albeit limited, to
determine the components in buthid venom that induce pain with
the goal of isolating peptides that discriminate among the DRG-
expressed VGSCs. For example, BmK I, isolated from the venom
of Buthus martensii Karsch, an Old World buthid (species that
originated in Africa and Asia), induces paw licking when injected
into the hind paws of rats. BmK I modulates DRG-expressed Na
+
currents in rat, but the specific ion-channel target was not
identified [16,17,18]. A separate study showed that BmK MI
(synonym for BmK I) slows the fast inactivation of Nav1.7
expressed in Xenopus ooctyes [19]. Toxins isolated from the Old
World buthids Odonthobuthus doriae (ODI), Androctonus australis
Hector (AahII) and Leiurus quinquestriatus hebraeus (LqhIII) also slow
the fast inactivation of Nav1.7 [19,20]. However, while the venoms
of these three scorpions are reported to be painful, ODI, AahII
and LqhIII were not tested for their ability to induce paw licking in
a rodent model. Collectively, the results from these studies support
the hypothesis that Old World buthids produce painful stings, in
part, by toxins that modulate DRG-expressed Na
+ channels. New
World buthids (species that originated in North and South
America) are reported to produce intensely painful stings, how-
ever, to our knowledge no studies have identified pain-inducing
components from the venoms of New World buthids.
The goal of this study was to gain a better understanding of how
neurotoxic venom produced by buthid scorpions induces pain in
mammals. Our objectives were to 1) establish in a mouse model
whether venom produced by buthid scorpions is more painful than
venom produced by scorpions from other families as anecdotally
reported; 2) determine whether Na
+ channel toxins are involved in
generating the intense pain produced by New World buthids, and
if so, identify their ion-channel targets and mechanism of action;
and 3) compare pain-inducing toxins from Old and New World
buthids to determine whether they employ similar venom
components to produce painful stings.
To achieve these objectives, we measured the duration of paw
licking by Mus musculus in response to injections of venom or
venom fractions into their hind paws. While we do not know what
mice perceive, we assume that mice lick their paws in response to
pain. Thus, we will refer to the venom and toxins that produce
paw licking as ‘‘painful’’ or ‘‘pain inducing.’’
Materials and Methods
This study was carried out in strict accordance with recom-
mendations in the Guide for the Care and Use of Laboratory
Animals of the National Institutes of Health. Protocols were
approved by the Institutional Animal Care and Use Committees at
the University of Texas at Austin, protocol number AUP-2009-
00027, and the Indiana University School of Medicine, protocol
number 3552. All efforts were made to reduce the number of
animals used and to minimize the suffering of animals.
Scorpion collection
Specimens of C. exilicauda (synonym for C. sculpturatus) and V.
spinigerus were collected from the foothills of the Santa Rita
Mountains, AZ. Specimens of C. vittatus were collected from the
foothills of the Organ Mountains, NM. Scorpions were collected at
night using ultraviolet light and then placed in plastic bags for
transport. Scorpions were housed in plastic containers (52 cm
L635 cm W615.6 cm H) in a room with a 12/12 light cycle and
daily temperature of 25–26uC. Aquarium gravel was used to line
the containers and cardboard egg crates were added to provide the
scorpions with a refuge. Scorpions were fed live crickets once a
week and provided with water ad libitum.
Venom extraction and preparation
Fresh venom was extracted from captive scorpions using
electrical stimulation of the telson (terminal tail segment that
houses the venom gland). The crude venom was dissolved in sterile
water and centrifuged at 14,500 RPM, 4uC, for 15 minutes to
remove insoluble components. The supernatant was collected and
the protein concentration determined using a nanodrop spectro-
photometer. For protocols isolating pain-inducing peptides from
venom, aliquots of the supernatant were stored for a short period
of time at 280u C and then thawed before applying the sample to
the perfusion column. For behavioral assays to screen venom and
venom fractions for pain-inducing capability, aliquots of soluble
venom were lyophilized and maintained at 220u C until tested.
Isolation of peptides that induce paw licking in mice
Venom peptides were purified by tandem purification. Soluble,
whole venom from C. vittatus was separated into fractions using
perfusion chromatography (1 dimension). Aliquots of whole venom
were injected into a POROS (PerSeptive Biosystems, Framing-
ham, MA) R2 10 mm perfusion column (4.6 mm internal
diameter6100 mm length). The perfusion column was connected
to a Bio Rad (Hercules, CA) Biologic Duoflow Maximizer system
with a Quad Tec UV-Vis detector. Fractions were separated using
the following method: linear gradient with 0% to 4% solvent B at
0.80 ml/min for 2.0 ml; linear gradient with 8% to 38% solvent B
at 0.80 ml/min for 80.0 ml; linear gradient with 44% to 100%
solvent B at 0.80 ml/min for 10.0 ml; isocratic flow with 0%
solvent A, 100% solvent B at 0.80 ml/min for 3.0 ml; linear
gradient with 100% to 0% solvent B at 0.80 ml/min for 3.0 ml;
isocratic flow with 100% solvent A, 0% solvent B at 0.80 ml/min
for 4.0 ml (solvent A, 0.1% trifluoroacetic acid in LC water;
solvent B, acetonitrile). The elution of each fraction was monitored
by following the UV trace at 214 nm and 280 nm. Fractions were
collected manually and screened for their ability to produce pain
using a behavioral assay (see below). Fractions that produced pain
were further separated into individual peptides using a TARGA
(Higgins Analytical, Inc., Mountain View, CA) reverse phase C18
column (4.6 mm internal diameter6250 mm length) (2 dimension)
and a different buffer system. Individual peptides were separated
using the following method: linear gradient with 0% to 8% solvent
B at 0.80 ml/min for 2.0 ml; linear gradient with 8% to 44%
solvent B at 0.80 ml/min for 80.0 ml; linear gradient with 44% to
100% solvent B at 0.80 ml/min for 10.0 ml; isocratic flow with
0% solvent A, 100% solvent B at 0.80 ml/min for 3.0 ml; linear
gradient with 100% to 0% solvent B at 0.80 ml/min for 3.0 ml;
isocratic flow with 100% solvent A, 0% solvent B at 0.80 ml/min
for 4.0 ml (solvent A, 100 mM ammonium acetate, pH 6.5, in LC
water; solvent B, acetonitrile). Peptides were collected manually by
following the UV trace at 214 nm and 280 nm. The purity of
peptides was confirmed using analytical HPLC (data not shown).
Purified peptides were tested for their ability to induce pain using a
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Behavioral assays
Soluble venom, venom fractions and purified peptides were
tested for their ability to produce pain using the paw-licking assay
[16,21]. For all behavioral assays, lyophilized samples of venom or
venom components were hydrated in sterile water to the final
concentration and injected subcutaneously into the plantar region
of the left hind paw of house mice (Mus musculus domesticus). To
control for the pain of an injection, aliquots of an equal volume of
sterile water were injected into the hind paw of an additional
group of mice. Immediately following the injection, mice were
placed in a Plexiglas container (8 cm W638 cm L626 cm H) and
their response was videotaped using a digital video camcorder
(Canon XL1 mini DV) equipped with a 36wide-angle zoom lens
(Canon XL 3.4–10.2 mm). The amount of time mice spent licking
their paws was measured and used as an index of pain.
In the first paw-licking assay comparing the pain-inducing
capability of soluble venom from three different species of
scorpion, samples of lyophilized venom were diluted to a
concentration of 1.7 mg/ml. An aliquot of 10 ml was injected into
the hind paw of male mice (strain CD-1, 37–40 g, n=8 per
treatment) and paw licking was recorded for 10 minutes. Data are
reported as the mean values in seconds (s) 61 standard error of the
mean (SE). A single factor analysis of variance (ANOVA, JMPH8,
www.jmp.com) was used to test for significant effects across
treatment groups. Planned orthogonal contrasts were used to test
for differences between treatments.
In the behavioral assays screening C. vittatus venom fractions and
purified peptides for pain-inducing ability, lyophilized venom
fractions or peptides were diluted to a concentration of 2.0 mg/ml.
A1 0ml sample was injected into the hind paw of female mice
(strain CD-1, 20–24 g, n=2–5 mice per treatment) and paw
licking was recorded for 5 minutes. Paw licking values for C. vittatus
venom fractions are reported as the mean (s) 61 SE. A single
factor ANOVA (JMPH8, www.jmp.com) was used to detect
significant differences in paw licking across all treatment groups.
A multiple comparisons test (Tukey’s HSD) was used to identify
venom fractions that produced as much paw licking as the sample
of whole venom. In order to reduce the number of mice used to
test samples and to conserve the limited supply of purified
peptides, only two mice were used to test each individual peptide
isolated from venom fractions. Measures of pain for purified
peptides are shown as paw licking values (s) from each of two tests
for each peptide.
Mass spectrometry analysis
The molecular mass of C. vittatus venom fractions and purified
peptides were estimated using matrix assisted laser desorption
ionization time of flight (MALDI TOF) technology. Mass
spectrometry was performed using an Applied Biosystems (Full-
erton, CA) Voyager Biospectrometry Workstation MALDI-TOF
mass spectrometer in the Institute of Cellular and Molecular
Biology Protein Microanalysis Facility of the University of Texas
at Austin. Aliquots of peptide samples in aqueous solution or
containing up to 50% acetonitrile were combined with freshly
prepared matrix solution [saturated sinapinic acid dissolved in a
mixture of 50 or 75% (v/v) acetonitrile, 0.3% (v/v) trifluoroacetic
acid (TFA) and distilled water]. Mass spectral measurements were
made with ratios of peptide solution to matrix solution ranging
from 1:1 to 1:6. The optimum ratio was typically 1:4, thus, all
reported spectra were made with a ratio of 1:4. Sample aliquots of
0.5 or 1.0 mL were spotted onto stainless steel sample plates and
spectra were collected by averaging 10–20 laser shots. Samples
were irradiated with a nitrogen laser (Laser Science Inc.) operated
at 337 nm, attenuated and focused on the sample target using the
built-in Perseptive GRAMS/386 software. Ions were accelerated
with a deflection voltage of 30 kV and differentiated according to
their m/z using a time-of-flight mass analyzer. Myoglobin (horse
heart; Mr 16,950.7), insulin (Mr 5,733.5) and Bradykinin (Mr
1,060.2) were used as external standards to calibrate the spectra.
Amino acid analysis (N-terminal Protein Sequencing)
After confirming the purity of the peptides isolated from C.
vittatus’ venom, the N-terminal amino acid sequence for each
peptide was determined using Edman degradation. Automated
protein sequencing was performed on a 492A protein sequencer
equipped with a 120A HPLC system (PE Applied Biosystems). All
reagents and solvents used for the sequencer were obtained from
PE Applied Biosystems. Aliquots of each peptide were reduced
with DTT and chemically modified with iodoacetamide. Briefly,
peptides were incubated with 100 mM DTT at 37uC for one hour
followed by incubation with 120 mM iodoacetamide at 37uC for
one hour. The peptides were then spotted onto either polybrene
(Bioprene) treated glass fiber disks or PVDF membrane pieces (ca.
161 mm). PVDF membrane pieces were wetted with neat
methanol and an aliquot of a 1 to 20 dilution of the Bioprene
solution while glass fiber disks were treated only with the
polybrene solution. Both the glass fiber disks and membrane
pieces were dried under a stream of nitrogen and then loaded into
the reaction cartridge for sequencing.
Molecular Analyses: cloning CvIV4 venom gland cDNA
RNA extraction and cDNA synthesis. Two female speci-
mens of C. vittatus (Organ Mountains, NM) provided the RNA for
molecular analyses of the gene that encodes toxin CvIV4. Total
RNA was extracted from the venom gland of scorpions 24 hours
following venom extraction. The telson was removed from each
scorpion and immediately frozen at 280u C. Frozen telsons were
homogenized in RNA STAT-60 (Tel-Test, Inc., Friendswood,
TX). Total RNA was isolated from the homogenate according to
the manufacturer’s guidelines. Complementary DNA (cDNA) was
generated from approximately 500 ng of total RNA. Oligo d(T)20
(www.invitrogen.com) was used to prime the polyadenylated (poly
A+) mRNA and Invitrogen SuperScriptH III Reverse Tran-
scriptase (www.invitrogen.com) was used to reverse transcribe the
mRNA.
Amplification of cDNA encoding CvIV4. The cDNA
prepared from C. vittatus venom gland RNA served as the tem-
plate to amplify the gene that encodes CvIV4. The polymerase
chain reaction (PCR) procedure was used to amplify cDNA in three
steps. In the first step, degenerate primers (1 and 2, Table 1) were
used to amplify the initial 148 nucleotides from the gene that
correspond to the beginning of the mature toxin. Degenerate
primers were designed from a combination of CvIV4 peptide
sequence (direct sequencing of peptide, Edman degradation) and
published scorpion toxin nucleotide sequences (NCBI). In the
second step, nested gene-specificforward primers (3 and 4,Table 1),
designed from the PCR product obtained during the first step, were
paired with a custom designed oligo d(T)24VN reverse primer (7,
Table 1, Integrated DNA Technologies, www.idtdna.com) to
amplify nucleotide sequence corresponding to the mature toxin
and the three prime untranslated region (39 UTR). In the third step,
nested gene-specific reverse primers (5 and 6, Table 1), designed
from the PCR products obtained during the first and second steps,
were paired with 59 RACE (rapid amplification of cDNA ends)
nested forward primers (see manufacturer’s protocol for inner and
CvIV4: A Pain Inducing a- Scorpion Toxin
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appliedbiosystems.com) to amplify nucleotide sequence corre-
sponding to the mature toxin, the signal peptide and the 59 UTR.
All PCR procedures used TaKaRa Ex Taq
TM polymerase (www.
takara-bio.com) to amplify the cDNA template according to the
manufacturer’s directions. PCR amplifications of gene sequence
were conducted using an Eppendorf Thermocyler and the products
were analyzed on 1% agarose gels. DNA fragments were extracted
from the agarose gels and purified using Invitrogen PureLink
TM
Quick Gel Extraction Kit (www.invitrogen.com).
Cloning and sequencing PCR products. Taq polymerase
amplified products from steps 1–3 were inserted into a plasmid
vector (pCRH4-TOPO, TOPO TA CloningH Kit for Sequencing,
www.invitrogen.com). Plasmid vectors with DNA inserts were used
to transform E. coli cells (One ShotH TOP10 Competent Cells,
www.invitrogen.com). Cloning and transformation procedures
were conducted following the manufacturer’s guidelines. Colonies
were selected and grown overnight in LB medium containing
50 mg/ ml kanamycin. E. coli cells were harvested from overnight
cultures and plasmids with DNA inserts were extracted and purified
using Qiagen’s QIAprep Spin Miniprep Kit (www.qiagen.com).
DNA samples were eluted in nuclease-free water and sequenced in
both directions using M13 Forward and M13 Reverse primers
supplied with the TOPO TA cloning kit. DNA samples were
sequenced at the University of Texas at Austin Institute for Cell &
Molecular Biology (ICMB) Sequencing Facility using capillary-
based Applied Biosystems 3730 and 3130 automated DNA
Analyzers. The nucleotide (cDNA) sequence encoding a clone of
CvIV4 has been deposited to the NCBI GenBank (accession
number JF938594).
Electrophysiological recordings
Plasmids of sodium channels. The cDNA genes encoding
rat (r) Nav1.2, rNav1.3 and rNav1.4 were inserted into the vectors
pRC-CMV, pcDNA3.1-mod and pRBG4, respectively [22,23,24].
The cDNA genes encoding human (h) Nav1.5 and hNav1.7 were
subcloned into the vectors pcDNA3.1 and pcDNA3.1-mod,
respectively [25].
Preparation of Stably Transfected Cell Lines. HEK293
cells were obtained from ATCC, Manassas, VA, USA. Use of the
HEK293 cells was approved by the Institutional Biosafety
Committee and conformed to the ethical guidelines for the
National Institutes of Health for the use of human-derived cell
lines. The transfections of all wild type sodium channels (Nav1.2,
Nav1.3, Nav1.4, Nav1.5, and Nav1.7) were carried out using the
calcium phosphate precipitation method as described by Xiao et al.
(2010). However, no b subunit or green fluorescent protein reporter
plasmid was included inthecalcium phosphate-DNA mixture.After
transfection of Human Embryonic Kidney cells (HEK) for 15–20 h,
the cells were washed with fresh medium. After 48 h, antibiotic
(G418, Geneticin; Cellgro, Herndon, VA) was added to select for
neomycin-resistant cells. After 2–3 weeks in G418, colonies were
picked, split, and subsequently tested for channel expression using
whole-cell patch clamp recording techniques.
Dorsal root ganglion (DRG) neuron preparation. Adult
rat DRG neurons were acutely dissociated and cultured as
previously described [26]. Briefly, rats were anesthetized by
exposure to CO2 and decapitated. Cells were treated with
collagenase (1 mg/ml) and papain (1 mg/ml), dissociated in
DMEM supplemented with 10% fetal bovine serum, and plated
on glass coverslips coated with polyornithine and laminin. Cultures
were maintained at 37uC in a 5% CO2 incubator, and media was
changed every 2 days during experimental incubation periods.
DRG neurons express both tetrodotoxin-sensitive (TTX-S) and
TTX-resistant (TTX-R) sodium channels. In order to isolate TTX-
R sodium current, DRG neurons were pretreated with 500 nM
TTX to block TTX-S sodium current.
Site-directed mutagenesis. Two hNav1.7 mutations (D1586A
and E1589Q, DIV S3–S4 loop) were constructed using the
QuikChange II XL Site-Directed Mutagenesis kit (Stratagene, La
Jolla,CA)andexpressedinHEK293cellsasdescribedbyXiaoetal.
(2010).
Whole-cell Patch Clamp Recordings. Whole-cell patch
clamp recordings were performed at room temperature (,21uC)
using an EPC-10 amplifier (HEKA, Lambrecht, Germany). Data
were acquired on a Pentium IV computer using the Pulse program
(version 8.31; HEKA). Fire-polished electrodes were fabricated
from 1.7-mm capillary glass (VWR, West Chester, PA) using a P-
97 puller (Sutter, Novato, CA). The standard pipette solution
contained (in mM): 140 CsF, 1 EGTA, 10 NaCl and 10 HEPES,
pH 7.3. The standard bathing solution was (in mM): 140 NaCl, 3
KCl, 1 MgCl2, 1 CaCl2 and 10 HEPES, pH 7.3. After filling with
pipette solution, the access resistance of electrode pipette ranged
from 0.8 to 1.4 MV. The liquid junction potential for these
solutions was ,8 mV; data were not corrected to account for this
offset. The offset potential was zeroed before contacting the cell.
After establishing the whole-cell recording configuration, the
resting potential was held at 2100 mV for 5 min to allow
adequate equilibration between the micropipette solution and the
cell interior. Linear leak subtraction, based on resistance estimates
from four to five hyperpolarizing pulses applied before the
depolarizing test potential, was used for all voltage clamp
recordings. Membrane currents were usually filtered at 5 kHz
and sampled at 20 kHz. Voltage errors were minimized using 80%
series resistance compensation, and the capacitance artifact was
canceled using the computer-controlled circuitry of the patch
clamp amplifier. The CvIV4 stock solution was made at 0.1 mM
using bathing solution containing 1 mg/ml BSA, and aliquots
were stored at 220uC. Before use, the solution was diluted to the
desired concentration with fresh bathing solution. Toxin (30 ml)
was added directly to the recording chamber (volume of 300 ml)
and mixed by repeatedly pipetting to achieve the specified final
concentration.
Data Analysis. Data were analyzed using the Pulsefit
(HEKA) and GraphPad Prism 4 (GraphPad Software) programs.
All data points are shown as the mean 6 SE and n represents the
number of separate experimental cells. Steady-state activation and
inactivation curves were fitted using Boltzmann equation: y=1/
(1+exp((V1/22V)/k), in which V1/2, V and k represented midpoint
Table 1. Primers for Amplification of cDNA Encoding CvIV4.
No. Sequence Direction
1Position
1 AARAARGAYGGNTAYCCNGTNGAN Forward 100–123
2 CVYTATCSGGWAGVCCKWVRCART Reverse 240–217
3 CACAGTGGTTGCAAATATACTTGTTGGAAA Forward 124–153
4 ACTTGTTGGAAAAACGAATATTGT Forward 141–165
5 TTTGTTTTTAAAGGTACGTTATCAGGAAGACCTGT Reverse 266–232
6 TGTTTACTTCCTTTTACCGTTACA Reverse 297–274
7 TTTTTTTTTTTTTTTTTTTTTTTVN Reverse 389–362
1Position of primer oligonucleotides with respect to CvIV4 cDNA sequence
shown in Fig. 4B.
doi:10.1371/journal.pone.0023520.t001
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Dose-response curves to determine EC50 values were fitted using
the Hill equation: y=fTOP(1+10‘((logEC502[Tx]/EC50)
nH), where
nH is Hill coefficient, EC50 is half maximal effective concentration,
and fTOP is the fraction of current sensitive to inhibition at high
toxin (Tx) concentration.
Results
Effects of scorpion venom on paw-licking behavior in
Mus
Tests quantifying the effects of the venoms of three different
species of scorpions on paw-licking behavior in M. musculus (strain
CD-1) showed that scorpion venom induces pain-related behaviors
in mice (Fig. 1). The amount of time mice spent licking their paws
in response to an injection of scorpion venom or water differed
among treatment groups (for all treatment groups n=number of
mice; C. vittatus, 130.23 sec622.08, n=8; C. exilicauda, 100.53 sec
612.42, n=8; V. spinigerus, 64.94 sec68.14, n=8; water, 4.36 sec
62.57, n=8; Fig. 1). A single factor ANOVA showed a significant
effect across treatment groups (F=16.40; df=3, 28; P,0.0001).
Planned orthogonal contrasts demonstrated that while the venom
of all three species of scorpion produced significantly more paw
licking in mice than the water control (F=37.25; df=1, 28;
P,0.0001), the venom of both species of Centruroides produced
significantly more paw licking than V. spinigerus venom (F=9.49;
df=1, 28; P=0.0046). Although the venom of C. vittatus induced
more paw licking than that of C. exilicauda, the difference was not
significant (F=2.47; df=1, 28; P=0.1275). These results indicate
that scorpion venom, at least the venom of the three species we
tested, is painful, not only to humans, but also rodents. Moreover,
the results show differences in the pain-inducing capability of
different species of scorpion, and they confirm anecdotal reports
that the venom of Centruroides is especially painful, whereas that of
V. spinigerus is much less so.
Isolation and identification of pain-inducing peptides
Because the venom of C. vittatus produced more paw licking
than that of C. exilicauda, we selected C. vittatus venom for
subsequent studies aimed at identifying the components in
scorpion venom that cause pain. High performance liquid
chromatography (HPLC) was used to separate C. vittatus whole,
soluble venom into five fractions, P1–P5 (Fig. 2A). Samples of each
fraction were tested for pain using the paw-licking assay on M.
musculus. The amount of time mice spent licking their paws in
response to an injection of water, scorpion venom, or venom
fractions differed significantly among treatment groups (for all
Figure 1. Mean (+1SE) duration of paw licking for Mus musculus
injected with scorpion venom or water. Samples of whole, soluble
venom from three scorpion species induced more hind-paw licking in
M. musculus than the water control during a ten-minute test period
following the injection (F=37.25; df=1, 28; P,0.0001). However,
Centruroides’ venom induced more paw licking than V. spinigerus
venom (F=9.49; df=1, 28; P=0.0046). There was no statistical
difference in the duration of paw licking induced by C. vittatus and C.
exilicauda venom (F=2.47; df=1, 28; P=0.1275).
doi:10.1371/journal.pone.0023520.g001
Figure 2. Effect of C. vittatus venom and venom fractions on
paw-licking behavior in Mus musculus. A. High performance liquid
chromatography (HPLC) profile of C. vittatus venom fractions. Whole,
soluble venom from C. vittatus was separated into five fractions (peaks:
P1, P2, P3, P4, P5). Each fraction was isolated and tested for pain using
the paw-licking assay in M. musculus. B. Mean (+1SE) duration of paw
licking for M. musculus injected with water, scorpion venom, or venom
fractions. Paw licking was recorded for five minutes following the
injection. P4 was the only fraction that was significantly more painful
than water (P,0.0001) and P4 induced as much pain as whole venom
(P=0.9525). Histograms showing the same letter did not differ at the
P,0.05 level of significance using Tukey’s HSD test.
doi:10.1371/journal.pone.0023520.g002
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n=5; C. vittatus venom, 86.87 sec67.62, n=6; P1, 33.00 sec6
10.77, n=3; P2, 9.33 sec610.77, n=3; P3, 1.23 sec67.05, n=7;
P4, 75.73 sec68.35, n=5; P5, 15.66 sec610.77, n=3; Fig. 2B) as
confirmed by an ANOVA test (F=19.89; df=6, 25; P,0.0001).
Multiple comparisons using Tukey’s HSD identified a single
venom fraction, P4, that produced as much pain as whole venom
(P=0.9525; histograms representing fractions that did not differ at
the P,0.05 level of significance using Tukey’s HSD test were
labeled with the same upper case letter; Fig. 2B). Fraction P4 was
also the only fraction that was significantly more painful than
water (P,0.0001).
Mass spectrometry analysis showed that P4 contained three to
four different components (data not shown). HPLC separation of
P4 produced four subfractions, P4-1–P4-4 (Fig. 3A). Samples of
each subfraction were isolated and tested for pain in M. musculus
using the paw licking assay. To reduce the amount of sample
consumed and the number of mice used, only two tests were
conducted per subfraction. Each sample was tested on two mice
and each mouse was injected only once. The four subfractions
differed dramatically in the duration of paw licking they produced.
Results from the first and second tests showed that subfraction P4-
1 had no effect on paw licking, P4-2 and P4-3 induced a brief
amount of paw licking, and P4-4 produced the longest duration of
paw licking (Fig. 3B). There also appear to be differences in the
latency to induce paw licking in the three subfractions causing
pain. For example, P4-2 produced paw licking in each of two test
mice 15 seconds after injection of the sample. P4-3 produced paw
licking 10 seconds and 30 seconds after injecting the sample into
the first and second test mice, respectively. P4-4 produced paw
licking at 60 seconds after injection into the first test mouse and
30 seconds after injection into the second test mouse. Paw licking
increased during the second minute of the test and peaked from
three to five minutes. Mice injected with P4-4 were still licking
their paws at the end of the five-minute test period.
Mass spectrometry analysis
We used matrix-assisted laser desorption ionization time of
flight (MALDI TOF) technology to determine the molecular mass
of P4-4. Mass spectrometry analysis showed that subfraction P4-4
is a single peptide with a molecular mass of 6904.2 atomic mass
units (amu, data not shown). These results demonstrate that P4-4
has a mass characteristic of scorpion toxins that bind Na
+
channels. Scorpion Na
+ channel toxins, also known as long-chain
toxins, are polypeptides that have a mass ranging from 6500 to
8500 amu [6]. This suggests that peptides in the venom of C.
vittatus that produce pain may function by binding Na
+ channels
expressed in pain-sensing neurons.
Amino acid sequence determination
Edman degradation provided the initial 40 amino acids from
the N-terminal sequence of P4-4 (Fig. 4A). A BLAST (NCBI)
search using the N-terminal sequence confirmed that P4-4 has a
primary structure that is characteristic of scorpion toxins that bind
Na
+ channels. C. vittatus P4-4 was then assigned the name CvIV4
following the general guidelines for nomenclature of scorpion Na
+
channel toxins.
Isolation of venom gland mRNA encoding CvIV4
A comparison of the N-terminal sequence for CvIV4 with other
scorpion Na
+ channel toxins revealed that CvIV4 has a primary
structure similar to alpha (a) toxins. The first seven amino acid
residues and the position of the first four cysteines are identical to a
number of scorpion toxins classified as a-toxins. However, CvIV4
also contains sequence that is unique. Given that the number of
amino acid residues identified from direct sequencing of a peptide
is limited, we isolated mRNA from the venom gland and
sequenced the cDNA that encodes CvIV4 so that we could
compare its structure with other scorpion a-toxins. Total RNA
was isolated from the venom gland of two specimens of C. vittatus
and reverse transcribed to produce cDNA. The gene encoding
CvIV4 (Fig. 4B) was cloned and sequenced from this cDNA
sample in three steps. In the first step, degenerate primers (see
Table 1 for all primer sequences) designed from scorpion Na
+
channel toxin sequences (NCBI) were used to amplify gene
sequence corresponding to the initial 148 nucleotides of the
mature toxin (approximately position 99-249, Fig. 4B). In the
second step, nested gene-specific forward primers were designed
from the nucleotide sequence obtained during the first step. These
forward primers were paired with an anchored oligo d(T) reverse
primer to amplify the gene from the middle of the toxin to the
poly-A tail (approximately position 124 to 389, Fig. 4B). In the
third step, nested gene-specific reverse primers were designed from
nucleotide sequence obtained during the first and second steps.
Nested gene-specific reverse primers were paired with 59 RACE
forward primers to amplify the gene from the middle of the toxin
to the 59 UTR (approximately position 1 to 297, Fig. 4B).
Figure 3. Effect of C. vittatus venom P4 subfractions on paw-
licking behavior in Mus musculus. A. High performance liquid
chromatography (HPLC) profile of C. vittatus venom P4 subfractions.
Fraction P4 was separated into four subfractions (P4-1, P4-2, P4-3, P4-4).
B. Duration of hind-paw licking by M. musculus injected with C. vittatus
P4 subfractions. Each sample was tested on two mice and each mouse
was injected only once. Paw licking was recorded for five minutes
following the injection. The paw licking values from both the first and
second tests are shown in plot. Note, values for the first and second
tests for P4-1 are identical and markers overlap.
doi:10.1371/journal.pone.0023520.g003
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degradation of the CvIV4 peptide with a translation of the
nucleotide sequence obtained from C. vittatus venom gland cDNA
shows that we isolated the gene that encodes CvIV4 (Fig. 4A). Of
the initial 40 amino acid residues from the peptide, 35 are identical
to the gene translation (five residues at the C-terminal end of the
peptide could not be identified using Edman degradation). In
addition, the first four cysteines are located in the same positions in
both the peptide and translated gene. BLAST (NCBI) searches
using both the CvIV4 nucleotide sequence and translated protein
identified similar Na
+ channel toxins from several other scorpion
species. An alignment of the translated gene for CvIV4 with toxins
from seven other species shows that CvIV4 is most similar to
CeII8, a Na
+ channel toxin isolated from the venom of the
Mexican scorpion Centruroides elegans (Fig. 5). CvIV4 and CeII8
share 64% of their amino acid residues. The first seven amino
acids from both toxins are identical and seven of their eight
cysteines (cysteines 1, 2, 3, 4, 5, 7, 8) are located in the same
positions. The location of cysteine 6 differs by only one residue
position. Interestingly, CeII8 has a primary structure similar to
other scorpion a-toxins, but is classified as a beta (b) toxin based
on electrophysiological assays [27]. CvIV4 shares over 50% of its
amino acid residues with six additional scorpion Na
+ channel
toxins (Fig. 5). The initial seven amino acid residues from these
toxins are highly conserved and their eight cysteines are located in
similar positions. Ts3 and TsV, isolated from the venom of the
South American scorpion Tityus serrulatus, are classified as a-toxins
based on electrophysiological data. Tst3 and TbTx5, isolated
from the South American scorpions T. stigmurus and T. bahiensis
respectively, are classified as a-toxins based solely on sequence
similarity to other a-toxins. Pg8, isolated from the African scorpion
Parabuthus granulatus, and LmNaTx10, isolated from the Asian
scorpion Lychas mucronatus, are also classified as a-toxins based
solely on sequence similarity.
Effects of CvIV4 on VGSC subtypes
Effects of CvIV4 on Na
+ current. CvIV4 induces pain in
mammals. Pain sensation is regulated, in part, by three VGSC
subtypes (Nav1.7, Nav1.8, Nav1.9) that are expressed in nociceptors.
We tested CvIV4 on hNav1.7 expressed in HEK cells and on
dissociated rat DRG, which express all three subtypes. Nav1.7 is
tetrodotoxin sensitive (TTX-S) while Nav1.8 and Nav1.9 are
tetrodotoxin resistant (TTX-R). Cells were depolarized to 210 mV
from a holding potential of 2100 mV and Na
+ current was
measured before and after the application of CvIV4. A comparison
of pre- and post-toxin current traces shows that CvIV4 slowed the
Figure 4. Amino acid sequence of subfraction P4-4 (CvIV4) and C. vittatus venom gland cDNA that encodes toxin CvIV4. A.
Comparison of amino acid sequences representing CvIV4. The upper sequence represents the initial 40 amino acids of the purified peptide obtained
from Edman degradation. Amino acid residues that could not be determined are shown as ‘‘X’’. The lower sequence represents the translation of
nucleotides from the cDNA encoding CvIV4 isolated from C. vittatus venom gland. Sequences representing the peptide and translated gene are
identical with the exception of the five amino acid residues (X’s) that could not be identified. B. Nucleotide sequence from venom gland cDNA that
encodes toxin CvIV4. Nucleotide sequence from the 59 and 39 untranslated region (UTR) is shown as lower case letters. Sequence from the mature
peptide is shown as upper case letters. Amino acid residues translated from nucleotide sequence are shown as upper case letters positioned below
their corresponding codons. Amino acids designating the signal peptide are underlined and shown in bold.
doi:10.1371/journal.pone.0023520.g004
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(Fig. 6A). However, CvIV4 had no effect on TTX-R current
recorded from DRG. As Nav1.9 currents disappear very quickly
under standard recording conditions in DRG neurons, the majority
of the TTX-R current recorded from the DRG neurons reflects the
activity of Nav1.8 currents. We did not see evidence that CvIV4
enhanced Nav1.9 currents in the DRG neurons. Thus, the results
identify Nav1.7 as the target of CvIV4, demonstrate that Nav1.8 is
not a target and suggest that CvIV4 does not enhance activity of
Nav1.9 currents.
Our molecular analyses of C. vittatus venom gland mRNA showed
that CvIV4 has a primary structure similar to a-toxins produced by
other scorpions. Scorpion a-toxins slow fast inactivation in VGSCs
and prolong Na
+ current through the pore. By slowing inactivation
and prolonging current in Nav1.7, the results confirm that CvIV4
functions as an a-toxin.
We tested CvIV4 on four additional Na
+ channel isoforms
expressed in HEK cells (rNav1.2, rNav1.3, rNav1.4, hNav1.5).
CvIV4 (1 mM) slowed the fast inactivation and prolonged current
in Nav1.2, Nav1.3, and Nav1.4, but had minimal affect on Nav1.5
(Fig. 6A). The dose-response curves for CvIV4 show that the toxin
produced the strongest effects on Nav1.2 and Nav1.4, moderately
strong effects on Nav1.3 and Nav1.7, and weak effects on Nav1.5
(EC50 values, in mM: Nav1.2, 0.58; Nav1.3, 1.31; Nav1.4, 0.53;
Nav1.5, 23.3; Nav1.7, 1.34; Fig. 6B). These results show that
CvIV4 is not selective for Nav1.7.
Effects of CvIV4 on Nav1.7. We wanted to know if CvIV4
had additional effects on the voltage-dependent properties of
Nav1.7. To test this, HEK cells expressing Nav1.7 were held at
2100 mV and then depolarized for 50 msec, in 5 mV steps, to
+120 mV (Fig. 7A). Na
+ currents were measured before (Fig. 7B)
and after (Fig. 7C) the application of CvIV4. A comparison of
current traces pre- and post-toxin showed that CvIV4 prolonged
the flow of Na
+ current through the channel, but did not affect the
peak amplitude of current. The fraction of peak current remaining
at 5 ms was approximately 0.5 (I5m s ). A current-voltage (I–V) plot
comparing peak currents pre- and post-toxin with the fraction of
current remaining at 5 ms (post-toxin) showed differences in the
amount of current remaining at different membrane potentials
(data not shown). This suggested that there might be a voltage-
dependent effect on toxin binding. To address this, we plotted the
percentage increase in the fraction of current at 5 ms (post-toxin)
Figure 5. Comparison of CvIV4 translated cDNA with Na
+ channel toxin sequence from other scorpion species. CvIV4 (underlined) is
aligned with seven toxin sequences from other species. Alignment is based on cysteine residue position (shaded background) and toxins are
arranged in order of descending percent identity with respect to CvIV4. Percent identify (%ID) is estimated from the number of amino acids shared by
two toxins (NCBI Protein BLAST). While CvIV4 (JF938594) and CeII8 (P0CH40) are structurally similar (64% ID), they are functionally different as CvIV4 is
classified as an a-toxin and CeII8 as a b-toxin (classification based on electrophysiological recordings from Na
+ channel subtypes). CvIV4 shares over
50% of its amino acid residues with the remaining six toxins. Ts3 (P01496) and TsV (P46115) are classified as a-toxins based on electrophysiological
studies of mammalian cells and tissues. Tst3 (P0C8X5), Pg8 (ACD35698), TbTx5 (P0C5K8) and LmNaTx10 (ACD35698) are classifed as a-toxins based
solely on sequence similarity. Cv=Centruroides vittatus,C e = Centruroides elegans, Tst=Tityus stigmurus,T s = Tityus serrulatus,P g = Parabuthus
granulatus,T b=Tityus bahaensis,L m=Lychas mucronatus. GenBank accession numbers are shown in parentheses following the toxin name.
doi:10.1371/journal.pone.0023520.g005
Figure 6. Effects of toxin CvIV4 on voltage-gated sodium channel isoforms. A. CvIV4 (1 mM) slowed the fast inactivation of isoforms Nav1.2,
Nav1.3, Nav1.4 and Nav1.7 expressed in human embryonic kidney cells (HEK). In contrast, CvIV4 had a minimal effect on Nav1.5 (expressed in HEK) and
no effect on neuronal TTX-R sodium current isolated from adult rat dorsal root ganglia (DRG) neurons (500 nM TTX was used to block TTX-S sodium
current). All sodium current traces were elicited by depolarizing to 210 mV from a holding potential of 2100 mV. B. Dose-response curves for CvIV4
slowing the fast inactivation of five sodium channel isoforms (Nav1.2–1.7).
doi:10.1371/journal.pone.0023520.g006
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the toxin increased from 260 mV to reach a peak at approximately
230 mV. The effects of the toxin began to decrease at 0 mV,
reaching the lowest point around 100 mV. The results demonstrate
that the toxin requires depolarizing potentials to slow channel
inactivation, however, strong depolarizing potentials decrease the
effects of the toxin.
While CvIV4 slowed channel inactivation, it had no effect on
the voltage dependence of steady-state inactivation (Fig. 7E). The
effect of CvIV4 on the voltage-dependence of activation was
minimal, as the membrane potential was shifted by only 24m V
(Fig. 7E).
We also analyzed the effects of CvIV4 on the rate of recovery
from inactivation. Cells were held at 2100 mV and then given a
depolarizing prepulse to 0 mV for 20 msec, followed by a step
back to 2100 mV with increasing duration to allow channels to
recover from inactivation. This was followed by a 20 msec test
pulse to 0 mV to activate those channels that had recovered from
inactivation. The results demonstrated that 1 mM of toxin
decreases the time constant for recovery by approximately 20%
(Fig. 7F).
Effects of CvIV4 on Nav1.2, 1.3, 1.4, 1.5. CvIV4 also
prolonged Na
+ current through four additional VGSC isoforms
(Nav1.2, Nav1.3, Nav1.4, Nav1.5). Plots of the percentage increase
in current at 5 ms (post-toxin) against membrane potential showed
that the effects of CvIV4 are voltage-dependent (Fig. 8A). The
results also showed that CvIV4 differed in its effects depending on
the channel subtype. Nav1.3, Nav1.2 and Nav1.4 showed increases
in the fraction of current present at 5 ms (I5m s ) that peaked at
40%, 50%, and 60%, respectively. The peak amplitude occurred
at approximately 0 mV for all three subtypes and strong
depolarizing potentials (+50 to +100 mV) decreased the effects
of the toxin. In contrast, CvIV4 had minimal effects on Nav1.5,
with the fraction of current at 5 ms reaching a peak of only 10%
around 220 mV.
We tested the effects of CvIV4 on the voltage-dependence of
activation and inactivation for Nav1.2, Nav1.3, Nav1.4 and
Nav1.5. A comparison of the fraction of current recorded over a
range of membrane potentials (pre- and post-toxin) for all four
subtypes shows that CvIV4 does not shift the voltage-dependence
of either activation or inactivation for any of the subtypes (Fig. 8B).
Comparison of CvIV4 with scorpion toxins that target
Nav1.7
CvIV4 has a primary structure similar to seven other scorpion
toxins (Fig. 5). However, of these seven toxins, only CeII8 has been
tested on Nav1.7. The remaining six toxins have not been tested
on Nav1.7. We wanted to compare the sequence for CvIV4 with
other scorpion toxins that modulate Nav1.7. A literature search
revealed four additional toxins isolated from Old World scorpions
[ODI, Odonthobuthus doriae; AahII, Androctonus australis Hector;
LqhIII, Leiurus quinquestriatus hebraeus; BmK MI (BmK I), Buthus
martensii Karsch] that target Nav1.7 [19,20]. Interestingly, all of
these peptides function as a-toxins, slowing the fast inactivation
and prolonging Na
+ current through Nav1.7. While the biological
activity of these toxins is similar to CvIV4, an alignment of CvIV4
with ODI, AahII, LqhIII and BmK MI (BmK I) showed that the
primary structure of CvIV4 is not similar to these Old World a-
toxins (Fig. 9). However, the number and position of cysteines is
conserved. In addition, there are six hydrophobic amino acids that
are conserved between CvIV4 and these Old World toxins that
correspond to positions important for the structure and function of
Figure 7. Effects of toxin CvIV4 on activation and inactivation of isoform Nav1.7 expressed in Hek293 cells. A. Depolarizing pulses in 5-
mV increments were used to elicit current from Nav1.7 expressed in HEK cells before (B) and after (C) the application of 1 mM CvIV4. D. Effects of 1 mM
toxin on the current-voltage relationship of Nav1.7. Currents not inactivated at 5 ms in the presence of 1 mM toxin were plotted as the percentage
increase in the fraction of current at 5 ms (I5m s ). E. Effects of CvIV4 on steady-state activation and inactivation of Nav1.7. When data points were fitted
with a Boltzmann equation, the V1/2 values were 290.261.2 and 294.161.6 mV before (filled circles) and after (open circles) toxin treatment,
respectively. F. Effect of CvIV4 on rate of recovery from inactivation at 2100 mV. Cells held at 2100 mV were given a depolarizing prepulse to 0 mV
for 20-ms followed by a step back to 2100 mV with increasing duration to allow channels to recover from inactivation, followed by a 20-ms test
depolarization of 0 mV to activate those channels that had recovered from inactivation. Data points presented as a fraction of the maximum
recovered current were fitted with single exponential function to estimate the time constant. The time constants were 58.7615.4 and 48.2615.3 ms
before (filled circles) and after (open circles) toxin treatment, respectively.
doi:10.1371/journal.pone.0023520.g007
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Fig. 9) that is critical for the biological activity of AahII [29].
Localization of amino acids critical for CvIV4 activity
Scorpion a-toxins bind to VGSCs at site 3 (Domain IV S3–S4
loop) [28,30]. To localize the residues in the DIV S3–S4 loop that
are critical for CvIV4 activity, we made two mutants of hNav1.7
channels and expressed them in HEK cells. The acidic residue Asp
(D, position 1586 in hNav1.7) is important for a-toxin activity. We
substituted the negatively charged Asp with a neutral Ala
(D1586A) and decreased the effect of CvIV4 on hNav1.7
(Fig. 10A). The acidic residue Glu (E, position 1589 in hNav1.7)
is also critical for a-toxin activity. Glu occurs at this same position
in Nav1.3 and Nav1.2, also targets of CvIV4. However, in Nav1.4
(target of CvIV4) a Gln (Q) occurs at this position. We substituted
the Glu in hNav1.7 with Gln (E1589Q) and reduced the effects of
CvIV4 (Fig. 10A). The results suggest that both Asp1586 and
Glu1589 are important for the effects of CvIV4 on Nav1.7.
However, while both substitutions reduced the effects of CvIV4 on
Nav1.7, neither abolished the effects of this toxin, which suggests
other residues in DIV S3–S4, or other channel regions, are
necessary for the activity of CvIV4.
Discussion
Differences in the pain-inducing capability of venom
Anecdotal reports suggest that the stings of buthid scorpions are
intensely painful, more so than the stings of other scorpions.
However, no studies have used a mouse model to quantify and
compare the pain induced by buthid and non-buthid venoms
[16,21,31]. We found that the venom of one species of scorpion
from the family Vaejovidae (V. spinigerus), whose sting is reported to
be moderately painful in humans, caused significantly more paw
licking in mice than did an injection of water. However, the venom
Figure 8. Effects of CvIV4 on activation and inactivation of Nav1.2, Nav1.3, Nav1.4 and Nav1.5. 50-ms depolarizing pulses were used to
elicit Na
+ current from channel isoforms expressed in HEK cells before and after the application of 1 mM CvIV4. Cells were held at 2100 mV.
Depolarizing potentials ranged from 2100 to +120 mV in 5-mV increments. A. Currents not inactivated at 5 ms in the presence of 1 mM toxin were
plotted as the percentage increase in the fraction of current at 5 ms (I5m s ). B. Effects of CvIV4 on steady-state activation and inactivation of Na
+
channel isoforms.
doi:10.1371/journal.pone.0023520.g008
Figure 9. Comparison of CvIV4 with Old World a-toxins that modulate Nav1.7. CvIV4 is aligned with ODI, BmK MI, AahII and LqhIII, Old
World a-toxins that slow the fast inactivation of Nav1.7. The biological activity of CvIV4 is similar to these peptides, but its primary structure is not.
Gaps were introduced to align cysteine residues (white font with black background). Hydrophobic residues (dark shaded background) that are critical
for a-toxin structure and function are conserved in CvIV4 at positions 5, 14, 22, 36, 43 and 49 [28]. CvIV4 shares a lysine (light shaded background)
with AahII (position 60) that is critical for the biological activity of AahII [29]. Additional amino acids that are identical among toxins are marked with
an asterisk (*). GenBank accession numbers: CvIV4 (JF938594), ODI (P84646), BmK MI (P45697), AahII (P01484), LqhII (P59355). MAFFT version 6 used
for sequence alignment (http://mafft.cbrc.jp/alignment/software/).
doi:10.1371/journal.pone.0023520.g009
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significantly more paw licking in mice than V. spinigerus venom.
These results demonstrate that vaejovid venom is painful to
mammals, however, the results agree with anecdotal reports that
buthid venom is considerably more painful. The results also show
that the sensation of pain produced by buthid stings is conserved
across mammals. We also observed differences between the two
species of Centruroides in their pain-inducing capability. Such
variability in painfulness may reflect different ecological and/or
evolutionary histories of these scorpions with their predators
[32,33].
Pain-inducing components in C. vittatus venom (CvIV4)
We screened fractions of C. vittatus venom for pain-inducing
capability and identified four fractions that produced paw licking
in mice. One of those fractions (P4) caused a response in mice
similar to the response induced by the whole venom. Fraction P4
contained four peptides, three of which produced paw licking. Of
those three, P4-4 (CvIV4) produced more than twice as much paw
licking as the other two peptides. While CvIV4 generated more
paw licking than the other peptides, its effects were not immediate,
but commenced between 30 and 60 seconds following an
injection. Moreover, paw licking was sporadic during the first
minute following the injection and did not reach a peak until the
third and fourth minutes of the test. In contrast, injections of either
whole venom or fraction P4 produced an immediate response.
Humans report that Centruroides’ stings produce immediate, intense
pain. This suggests that other components in C. vittatus venom may
be necessary for producing an immediate response. While the
other three peptides in fraction P4 (P4-1, P4-2, P4-3) did not
generate as much paw licking as CvIV4, they may be responsible
for initiating an immediate pain response. Fractions P1, P2 and P5
produced low to moderate amounts of paw licking, while fraction
P3 failed to produce a response. It is possible that one or more of
these fractions, either individually or in combination, are critical
for initiating an immediate pain response in mammals.
Structural characteristics of CvIV4
The molecular mass and the initial 40 amino acids of the
N-terminal sequence for CvIV4 are characteristic of scorpion
toxins that bind Na
+ channels [6,34]. Scorpion toxins that bind
voltage-gated Na
+ channels are polypeptides composed of a single
strand of amino acids. The peptides range from 58 to 76 amino
acids in length (6500–8500 amu) and they contain eight cysteines
that form four disulfide bonds. The conserved structural scaffold of
these peptides consists of one a-helix and two or three strands of b-
sheet, typically arranged in the order babb. We isolated cDNA
clones from C. vittatus venom gland mRNA and identified a clone
whose translated nucleotide sequence matched the N-terminal
amino acid sequence of CvIV4. A comparison of the translated
cDNA with sequences from other scorpion toxins confirmed that
CvIV4 is a Na
+ channel toxin.
Na
+ channel toxins can be divided into two groups (alpha and
beta) based on their functional effects [6,7]. Beta (b) toxins shift the
voltage-dependence of activation to more negative potentials,
making the channel more likely to open at membrane potentials
where activation would normally not occur. Alpha (a) toxins
inhibit the fast inactivation mechanism, prolonging Na
+ current
through the channel. While a- and b-toxins are structurally
conserved, they are not identical. A BLAST search (NCBI)
revealed that the primary structure of CvIV4 is most similar to the
structure of venom peptides classified as a-toxins [6,28,35]. CvIV4
contains eight cysteine residues whose pattern is highly similar to
other scorpion a-toxins. In addition, the composition and location
of amino acid residues corresponding to the a-helix and b-sheets
conserved among a-toxins are also observed in CvIV4. The
primary structure of CvIV4 is most similar to CeII8, a toxin
recently isolated from the venom of Centruroides elegans [27]. CvIV4
and CeII8 share 64% of their amino acids, however, CeII8 is
classified as a b-toxin based on its functional effects.
Functional characteristics of CvIV4
Noxious stimuli activate nociceptors located in the peripheral
sensory pathway. Nociceptors express three different VGSC
subtypes (Nav1.7, Nav1.8, Nav1.9) that play a role in regulating
pain perception. We tested CvIV4 on hNav1.7 expressed in HEK
cells and on whole cell Na
+ currents recorded from rat DRG. We
found that the toxin slowed the fast inactivation of hNav1.7,
however, CvIV4 had no effect on TTX-R currents recorded from
DRG. Nav1.7 is TTX-S, while both Nav1.8 and Nav1.9 are TTX-
R. Thus our findings demonstrate that CvIV4 targets Nav1.7 and
not Nav1.8. Although the pharmacology of Nav1.9 currents are
Figure 10. Effects of CvIV4 on mutant Nav1.7 channels expressed in HEK293 cells. A. Substitution of negatively charged amino acids in the
Domain IV S3–S4 loop with neutral residues (D1586A, E1589Q) reduces the effects of 1 mM CvIV4 on Nav1.7. B. Dose-response curves for CvIV4 on
wildtype and mutant Nav1.7 channels.
doi:10.1371/journal.pone.0023520.g010
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also suggest that CvIV4 does not enhance Nav1.9 currents. This
suggests that CvIV4 induces pain in mammals by slowing the fast
inactivation of Nav1.7.
By slowing the fast inactivation of Nav1.7, CvIV4 induced a
persistent Na
+ current, but did not change the peak amplitude of
the current. The persistent Na
+ current could be abolished by
strong depolarizing membrane potentials, which suggests that
CvIV4 dissociates from its target at highly positive membrane
potentials. CvIV4 had no effect on the voltage-dependence of
inactivation and shifted the voltage-dependence of activation to
the left by only 4 mV. All of these effects are characteristic of the
activity reported for scorpion a-toxins [7,17,19,20,28,30,36]
confirming that CvIV4 functions as an a-toxin. Moreover, these
findings provide a mechanism to explain how CvIV4 produces the
sensation of pain in mammals. By prolonging Na
+ current in
Nav1.7, CvIV4 would cause nociceptors to become hyper-
excitable, thus producing the sensation of pain.
Purified samples of CvIV4 induced paw licking in mice,
however, the response was delayed as compared to whole venom
or fraction P4. It is possible that one of the other fractions or
peptides isolated from C. vittatus venom is necessary for initiating
immediate pain sensation. A recent study of Centruroides elegans
venom components showed that CeII8 binds Nav1.7 expressed in
Xenopus oocytes [27]. In contrast to CvIV4, CeII8 acts as a b-toxin
and shifts the voltage-dependence of activation to more negative
potentials, making Na
+ channels more likely to open. Because b-
toxins make Na
+ channels more likely to open at subthreshold
membrane potentials, it is plausible that b-toxins are responsible
for inducing the immediate sensation of pain associated with
scorpion stings. However, the study of Centruroides elegans venom did
not directly test whether CeII8 produces paw licking in mammals.
Results from the electrophysiology data showed that micro-
molar concentrations of CvIV4 were required to slow the
inactivation of Nav1.7. However, we do not know the concentra-
tion of CvIV4 delivered in a single sting. Nor do we know whether
or how CvIV4 interacts with other toxins in the venom to produce
the sensation of pain in rodents. Interestingly, a recent study in
Xenopus oocytes indicated that sodium channel b subunits can
modulate the affinity of Nav1.8 channels for conotoxins [37].
Other studies have reported that b subunits do not alter the
interaction of sodium channels with neurotoxins in mammalian
cells [38]. It is possible that specific b1–4 subunit combinations
might alter the affinity of specific sodium channel isoforms for
CvIV4. Unfortunately, it is not known which b subunits associate
with Nav1.7 in DRG neurons.
CvIV4 also slowed the fast inactivation and produced a
persistent Na
+ current in rNav1.2, rNav1.3 and rNav1.4. However,
CvIV4 had a minimal affect on hNav1.5. These findings show that
CvIV4 is not selective for Nav1.7, but instead binds several VGSC
isoforms. This is in contrast to CeII8, which is selective for Nav1.7
[27]. Given that CvIV4 and CeII8 are similar in structure but
differ in function and isoform selectivity, a comparison of these two
toxins should improve our understanding of the structural
characteristics that determine New World scorpion toxin selectiv-
ity and function.
Four Old World a-toxins, ODI, isolated from the Iranian
scorpion Odonthobuthus doriae, AahII, from the African scorpion
Androctonus australis Hector, LqhIII, from the Middle Eastern
scorpion Leiurus quinquestriatus hebraeus and BMK MI (BmK I), from
the Asian scorpion Buthus martensii Karsch, all slow the inactivation
of Nav1.7 [16,17,19,20,31]. Anecdotal reports suggest that all four
of these scorpion species produce painful stings. However, of the
four toxins, only BmK MI (BmK I) has been tested for its pain-
inducing capability in mammals. While the biological activity of
CvIV4 is similar to these four toxins, the primary structure of
CvIV4 is not similar. However, eight cysteines and six hydropho-
bic amino acids that are critical for the structure and function of a-
toxins are conserved between CvIV4 and these four toxins [28].
Moreover, CvIV4 shares a lysine residue with AahII that is
important for the activity of AahII [29]. These results raise
intriguing questions about the evolution of pain-inducing toxins in
buthid scorpions. Old and New World scorpions diverged from a
common ancestor approximately 150 million years ago [39]. It is
possible that pain-inducing toxins evolved before the split between
Old and New World scorpions, and were then conserved.
Alternatively, pain-inducing toxins may have evolved separately
in both groups since their divergence. Identification and
comparison of additional pain-inducing toxins from both Old
and New World scorpions would provide insight into the evolution
of these toxins in Buthidae scorpions.
For scorpions like C. vittatus that are small and have slender
pincers, venom that induces pain may provide the opportunity to
escape from potential predators. In a series of staged feeding trials,
wild-caught grasshopper mice (Onychomys arenicola, O. torridus),
voracious predators of scorpions, were fed a variety of their local
prey items, including Centruroides spp., Vaejovis spp. and field
crickets [32]. Both O. arenicola and O. torridus dropped C. vittatus and
C. exilicauda (respectively) significantly more often than they
dropped the Vaejovis species or the crickets. This suggests that
CvIV4 may function as a defense against predators of C. vittatus.
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